Improved Patient Outcomes When Transmyocardial Revascularization Is Used as Adjunctive Revascularization


  • Kurt E. Wehberg
  • J. Stephens Julian
  • James C. Todd III
  • Nicholas Ogburn
  • Edward Klopp
  • Michael Buchness



Background: Transmyocardial revascularization (TMR) has been recently used to treat patients with angina for whom angioplasty/stenting and/or coronary artery bypass grafting (CABG) is no longer an option.

Methods: A retrospective review of 255 consecutive patients who required CABG was done. Group 1 patients (n = 219) underwent complete revascularization with CABG alone. Group 2 patients (n = 36) received CABG plus TMR. TMR was performed in regions of nongraftable coronary targets. Indications for surgery in both groups were Canadian Cardiovascular Society angina scores III or IV and an ejection fraction ³ 30%. Exclusion criteria were an emergency procedure within 12 hours, unstable angina, or an acute myocardial infarction within 72 hours. Thirty-day outcomes of the two groups were compared. The means ± SD of patient ages (63.3 ± 1.6 years versus 65.4 ± 1.4 years) and ejection fractions (51.6% ± 0.9% versus 48.5% ± 1.6%) were similar for the two groups.

Results: The number of grafts performed and operating room times for the two groups were similar (3.1 ± 0.1 versus 2.9 ± 0.1 and 276.7 ± 4.4 minutes versus 272.3 ± 10.7 minutes, respectively). Intensive care unit times and lengths of stay (emergency room to discharge) were significantly shorter in the CABG plus TMR group (2.1 ± 0.2 days versus 1.6 ± 0.2 days [P < .001] and 8.2 ± 0.4 days versus 7.1 ± 0.6 days [P < .001], respectively). The 30-day readmission rate was lower in the CABG plus TMR group (7.8% versus 2.8%; P < .5). The frequency of atrial fibrillation was also significantly lower in the CABG plus TMR group (37.4% versus 16.7%; P < .025). Major adverse outcomes, such as reoperation for bleeding, respiratory failure, renal failure, stroke, and mortality were similar in the two groups, although there were no mortalities in the CABG plus TMR group.

Conclusion: TMR as an adjunctive revascularization to CABG in selected patients with limited options may improve in-hospital outcomes.


Allen KB, Dowling RD, DelRossi AJ, et al. 2000. Transmyocardial laser revascularization combined with coronary artery bypass grafting: a multi-center, blinded, prospective, randomized, controlled trial. J Thorac Cardiovasc Surg 119:540-9.nAllen KB, Dowling RD, Fudge TL, et al. 1999. Comparison of transmyocardial revascularization with medical management in patients with refractory angina. N Engl J Med 341:1029-36.nBurkoff D, Schmidt S, Schulman SP, et al. 1999. Transmyocardial laser revascularization compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomized trial. Lancet 354:885-90.nCooley DA, Frazier OH, Kadipasaoglu KA, et al. 1996. Transmyocardial laser revascularization: clinical experience with twelve-month follow-up. J Thorac Cardiovasc Surg 111:791-9.nHorvath KA, Aranki SF, Cohn LA, et al. 2001. Sustained angina relief 5 years after transmyocardial laser revascularization with a CO laser. Circulation 104(suppl):I-81-4.nHorvath KA, Mannting F, Cummings, Sherman SK, Cohn LH. 1996. Transmyocardial laser revascularization: operative techniques and clinical results at two years. J Thorac Cardiovasc Surg 111:1047-53.nPrendergast BD, Campanella C, Shaw TR. 2001. Influence of the availability of laser transmyocardial revascularization on surgical strategy in patients with advanced coronary artery disease. Cardiology 95:90-5.nSen PK, Daulatram J, Kinare SG, Udwadia TE, Parulkar GG. 1968. Further studies in multiple transmyocardial acupuncture as a method of myocardial revascularization. Surgery 64:861-70.nStamou SC, Boyce SW, Cooke RH, Carlos BD, Sweet LC, Corso PJ. 2002. One-year outcome after combined coronary artery bypass grafting and transmyocardial laser revascularization for refractory angina pectoris. Am J Cardiol 89:1365-8.n



How to Cite

Wehberg, K. E., Julian, J. S., III, J. C. T., Ogburn, N., Klopp, E., & Buchness, M. (2005). Improved Patient Outcomes When Transmyocardial Revascularization Is Used as Adjunctive Revascularization. The Heart Surgery Forum, 6(5), 328-330.